The Genetic Regulation of Aortic Valve Development and Calcific Disease

Area of Science:

• Cardiovascular Biology
• Molecular Pathology
• Biomedical Engineering

Background:

• Heart valves are crucial for unidirectional blood flow, opening and closing over a billion times.
• Over 5 million Americans experience heart valve dysfunction due to wear-and-tear or disease.
• Calcific aortic valve disease (CAVD) is the most prevalent pathology, causing aortic stenosis and insufficiency.

Purpose of the Study:

• To review the multifactorial mechanisms underlying CAVD pathogenesis.
• To explore novel therapeutic targets for CAVD beyond surgical interventions.

Main Methods:

• Literature review of molecular pathways and cellular processes in CAVD.
• Analysis of cellular dysfunction, including endothelial cell changes and interstitial cell differentiation.
• Examination of dysregulated developmental pathways (Notch, Sox9, Tgfβ, Bmp, Wnt) and epigenetic regulators.

Main Results:

• CAVD involves valve endothelial cell dysfunction and osteoblast-like differentiation of valve interstitial cells.
• Key molecular pathways like Notch, Sox9, Tgfβ, Bmp, and Wnt are dysregulated in CAVD.
• Epigenetic regulators also play a significant role in CAVD development.

Conclusions:

• CAVD pathogenesis is complex, involving multiple molecular and cellular mechanisms.
• Targeting these identified pathways offers potential for developing novel therapeutics for CAVD.
• Future research may lead to non-surgical treatment options for this common heart valve disease.